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To unveil some molecular mechanisms underlying lithium toxicity, expression changes of stress-related genes or proteins were analysed in
A549 cells, cultured for 3 days in presence of lithium. A dose-dependant cell-growth inhibition was found for concentrations ranging from 2
(toxicity threshold) to 12 mM (lethality threshold). cDNA arrays technology was used to analyse effects of 5 and 10 mM lithium. Among genes
involved in cell cycle regulation, proliferating cell nuclear antigen (PCNA) was down-regulated and cyclin kinase inhibitor p21 (CDKN1A), up-
regulated. Genes of paraoxonase 2, known to prevent LDL lipid peroxidation, and of catalase and SOD were found to be down-regulated whereas
genes of cytochrome P450 (CYP2F1, CYP2E1) were up-regulated. This probably results in higher intracellular levels of reactive oxygen species
and account for increased levels of lipid peroxidation commonly associated with lithium exposure. Moreover, lithium was found to down-regulate
genes coding for anti-apoptotic gene BAG-1 and for most of the molecular chaperones (HSP, GRP). This might account for lithium toxicity since
these proteins are critical for cell survival. At translational level, a 105 kDa protein was found to be over-expressed. This protein was recognized
by the anti-GRP94, anti-KDEL and anti-phosphoserine monoclonal antibodies suggesting that, lithium could induce post-translational
modifications of GRP94 phosphorylation. Using tunicamycin and thapsigargin, it was concluded that lithium effects are not related to defect in N-
linked glycosylation and/or to changes in calcium homeostasis.
© 2007 Elsevier B.V. All rights reserved.Keywords: Lithium; oxidative stress; Cytochrome P450; HSP; GRP941. Introduction
Lithium is a toxic alkaline metal which naturally occurs in all
soils at concentrations up to 200 μg/g [1]. It is present in surface
water at concentrations of 1–10 μg/ml that can reach 5 mg/L in
river water of some regions of northern Chile [1] or 8 mg/L in
drinking water of some places of Texas [2]. Moreover, lithium
accumulates in marine animals, algae, vegetables or tobacco
leaves. Grains and vegetables are the primary dietary sources of
lithium and may contribute from 66% to 90% of the total
lithium intake [1]. Industrial use of lithium, which includes
production of metal alloys, ceramics, TV screens, color films,
pool cleaning chemicals, and batteries [3] contribute to
environmental pollution.⁎ Corresponding author. Tel.: +33 561 145 940; fax: +33 561 145 945.
E-mail address: croute@cict.fr (F. Croute).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.04.007Little informations are available on the inhalation toxicity of
lithium, although nasal irritations and coughing were reported
in occupationally exposed workers [3]. Rats exposed for 4 h to
aerosols containing 80% lithium carbonate displayed ulcerative
rhinitis often accompanied by squamous metaplasia, necrotic
laryngitis and respiratory difficulties [4]. Moreover, signs of
anorexia and dehydration were observed, showing that inhaled
lithium easily cross lipid-rich layer lining the lung alveolar
surface and can reach kidney via the blood.
Lithium toxicity has raised concern because it is widely
prescribed to cure bipolar disorders [5,6] and that numerous
undesirable side effects were observed during prolonged
treatment, such as gastro intestinal, renal, neurological and
endocrine disorders [7–11]. Serum lithium levels from 0.5 to
0.8 mM are usually recommended for maintenance treatment
[12,13]. Nevertheless, because they are most effective, doses
resulting in serum levels from 0.8 to 1.2 mM are widely used,
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Various studies suggest that some harmful effects of lithium
could be related to oxidative stress [15–17], whereas at
therapeutic concentration it was found to confer protection
against toxic stimuli inducing oxidative stress and apoptosis
[18–21]. According to Shaldubina et al. [22] the current
challenge is to distinguish critical effects from the many known
biochemical actions of lithium.
The present work was designed as a contribution to
understand some of the cellular mechanisms underlying the
lithium toxic effects. As lithium was found to be a respiratory
tract irritant, lung alveolar human cells (A549) were chosen as
cellular models. Lithium toxicity was evaluated by culturing
A549 cell line for 3 days in the presence of increasing
concentrations of lithium carbonate, to determine concentra-
tions that inhibited cell growth without inducing cell death. For
this range of concentrations, we looked for the effects of lithium
on the cellular stress response by quantifying expression
changes of stress-related genes using Human Stress Arrays.
Special attention was paid to genes encoding proteins involved
in cell cycle regulation (cyclin-dependant kinase inhibitor p21,
proliferating cell nuclear antigen), apoptosis (BAG-1), anti-
oxidant defences (superoxide dismutases, catalase, peroxi-
dases), cell detoxification (cytochome P450) and in protein
folding. When protein folding is affected by environmental
conditions, a signalling response is activated, inducing the
overexpression of specific molecular chaperones [23]. Among
molecular chaperones involved in cellular protein quality
control, the cytosolic resident heat-shock proteins (HSP27,
HSP72, HSP90) and the glucose-regulated proteins (GRP78,
GRP94) located in the endoplasmic reticulum (ER) were
analysed. Over-expression of HSP27, which is generally
thought to protect from apoptosis, can be triggered by a variety
of stimuli [24,25]. HSP 70 family was extensively used as
marker of an increasing flux of non-native or misfolded proteins
resulting from heat shock, oxidative stress, or chemical
aggressions [26–28]. HSP90 is a chaperone involved in the
regulation of signal transduction pathways by assisting
structural changes of steroid receptors and several kinases
[29]. GRPs are known to be involved in secretory processes,
their expression level is increased under stressing conditions
such as Ca++ depletion, glucose starvation or accumulation of
misfolded or underglycosylated proteins, which disrupt ER
function [30–32].
2. Materials and methods
2.1. Chemicals and reagents
Lithium carbonate (Li2CO3) and lithium chloride (LiCl) pro analysis grade
were from Prolabo/Rhone-Poulenc (France). Monoclonal antibodies raised
against HSP27 (SPA800), HSP72 (SPA 811), HSP72/73 (SPA 820) HSP90αβ
(SPA830), GRP78 (SPA827), GRP94 (SPA850) were purchased from StressGen
Biotechnologies (Victoria, BC, Canada). Monoclonal anti-phosphoserine,
proteases inhibitors, i.e., phenylmethanesulfonyl fluoride (PMSF), N-ethylma-
leimide (NEM), and aprotinin were purchased from Sigma-Aldrich (St. Quentin
Fallavier, France). Foetal calf serum (FCS) and other cell culture reagents were
from Institute Jacques Boy (Reims, France). Atlas™ Nylon cDNA arrays
(Human stress arrays, 7747-1) were from CLONTECH.2.2. Cell cultures
The A549 cell line has been established in permanent culture from a human
lung adenocarcinoma [33]. In vitro, these cells are largely differentiated as type
II-alveolar epithelial cells and they secrete their typical product the surfactant
[34]. They were cultured at 37 °C in Dulbecco's modified Eagle Medium
(DMEM, 25 mM glucose, pH 7.2) supplemented with 10% FCS and 20 μg
gentamycin in a humidified 5% CO2 atmosphere.
2.3. Treatment by lithium salts (Li2CO3, LiCl) or other chemicals
Cells were seeded at a density of 300,000 cells in Petri dishes (6 cm diameter)
containing 6 ml culture medium and allowed to attach overnight. Then, Li2CO3
or LiCl (final concentrations 2, 4, 6, 8, 10 and 12 mM) were added 18 later. For
each separate experiment, six control cultures (C) and six cultures for each Li
concentration were cultured in parallel for 3 days. Similar protocol was used in
order to analyse dose-effects of tunicamycin (0.5, 1 and 1.5 μg/ml) and
thapsigargin (2, 4, 6, 8 nM). Three dishes were used for growth rate analysis and
three dishes for the assay of total protein content in culture and stress protein
quantification.
2.4. Cell proliferation rate
Cell growth rate was evaluated (1) by cell counting in a suspension obtained
by trypsin-EDTA treatment (Coulter Counter, Coultronics, France) and (2) by
measuring the total protein content in rinsed cell layers using the Lowry's
method [35]. Cell death was detected by Trypan blue coloration.
Cell growth inhibitions were expressed as percent of controls normalized to
100%. The lowest concentration which led to a significant decrease of cell
growth, as compared to controls, was considered as the threshold concentration
for toxicity (Lowest Observed Effect Concentration, LOEC). Concentrations
which inhibited cell growth by 50% (IC50) were calculated from growth
inhibition curves.
2.5. Stress gene expression analysis using Human stress arrays
The culture medium of control cells or cultured for 3 days in presence of 5 or
10 mM of lithium carbonate was rapidly sucked out and cell layers were frozen
at −80 °C until analysis.
Total RNAs were extracted using the RNABle procedure (Eurobio).
cDNA probe synthesis and hybridization were carried out as specified by
the manufacturer (Clontech). Briefly, the polyA+ RNA fraction was isolated
with biotinylated oligo-dT bound to streptavidin-coated magnetic beads.
32P-labeled cDNA probes were synthesized on captured polyA+ RNA with a
MMLV reverse transcriptase in the presence of [α-32P] ATP and a gene
specific primer mix. This mix only contained primers for genes represented
on the array. This procedure provides the lowest background signal by
concentrating the entire radioactive label into the newly synthesized DNA.
32P-labeled cDNA probes were purified on a chromatography column and
labeling was checked by scintillation counting. Probes were then hybridized
onto the cDNA arrays which contain duplicate spots of cDNA fragments
from 234 human genes involved in the stress response. Hybridized
membranes were imaged with a scanner phosphorimager. Comparison of
expression profiles and quantitative analysis were carried out using the
Atlas image™ (Clontech) program. The global normalization mode was
used to normalize the signal intensity between the two arrays being
compared.
2.6. Stress protein expression on Western blot
Cell layers were rinsed with ice-cold phosphate-buffered saline (PBS, pH
7.4), collected into a lysis buffer (PBS containing 0.5% NP40 and protease
inhibitors: 10 mM EDTA, 1 mM PMSF and NEM, 1 μg/ml aprotinin, pH 7.4)
and frozen at −20 °C. 100 μl of lysis buffer was used for about 6×105 cells.
For analysis, cell lysates were sonicated for 10 sec and protein
concentration was determined using the Lowry's method [35]. Equal amounts
of proteins (20 μg) from each homogenate were separated by SDS-PAGE
Table 1
Expression changes of transcripts from stress genes in A549 cells cultured for
3 days in presence of 5 or 10 mM Li2CO3
Functions Li 5 mM Li 10 mM Genes/proteins
Cell cycle
regulation
1.26±0.03 3.20 Cyclin-dependent kinase inhibitor 1
(CDKN1A)
0.77±0.20 0.31 Proliferating cyclic nuclear antigen
(PCNA); cyclin
Apoptosis 0.16±0.11 0.15 BCL-2 binding athanogene-1
(BAG-1)
Antioxidant
enzymes
0.74±0.05 0.59 Cytosolic superoxide dismutase 1
(SOD1)
0.77±0.18 0.64 Mitochondrial superoxide
dismutase (SOD2)
0.76±0.01 0.88 Catalase (CAT)
1.25±0.06 1.53 Glutathione reductase (GRase)
1.10±0.14 1.16 Glutathione peroxidase (GPX1)
0.78±0.05 1.28 Glutathione peroxidase (GPX2)
1.02±0.11 0.80 Glutathione S-transferase 12
(GST12; MGST1)
0.39±0.15 0.28 Serum paraoxonase/arylesterase 2
(PON2)
Transcription
factor
1.14±0.41 0.95 Heat shock factor HSF1
Molecular
chaperones
0.48±0.04 0.40 HSP10
0.73±0.13 0.48 HSP27
0.82±0.12 0.38 HSP32 (heme oxygenase1)
0.88±0.04 1.00 HSP40
0.59±0.04 0.47 HSP47
0.37±0.25 0.65 HSP60
0.77±0.15 0.55 HSP70.1(HSP72)
1.52±0.06 1.00 Heat shock-related 70-kDa protein 2
0.91±0.05 0.98 Heat shock 70-related protein
APG-2
0.93±0.10 0.88 HSP73
(heat shock cognate HSC70)
1.16±0.24 0.81 HSP90A
0.97±0.07 0.86 HSP90 B
0.53±0.20 0.52 HSP110
0.62±0.06 0.50 Mitochondrial GRP75;
0.82±0.20 0.61 Calreticulin. calregulin
0.59±0.18 0.57 Reticulum endoplasmic GRP 78
0.62±0.14 0.46 Reticulum endoplasmic GRP94
Xenobiotique 2.21±0.54 2.61 Cytochrome P450 IIE1 (CYP2E1)
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membrane (70 V, 90 min).
To saturate the unspecific sites, the membranes were incubated for 1 h at
37 °C into a Tris-Buffered Saline (TBS: 10 mM Tris, 140 mM NaCl, pH 7.4)
containing 0.5% Tween20 (TBST). The membranes were then incubated for
1 h at room temperature under continuous shaking in the presence of primary
antibodies against HSP27, HSP72, HSP90, GRP78 and GRP94, diluted
respectively in PBST to 1/20000, 1/10000, 1/20000, 1/4000 and 1/30000,
then allowed to stand overnight at 4 °C. Monoclonal anti-phosphoserine was
diluted to 1/60000. After washing into (1) TBS for 5 min (twice), (2) TBS
containing 0.1% Nonidet-P40 for 15 min and (3) TBS for 5 min (twice),
blots were incubated at room temperature, in darkness, for 2 h under
continuous shaking in the presence of peroxidase-conjugated secondary
antibody diluted in TBS containing 3% dried skimmed milk. After washing,
the detection was carried out using SuperSignal® West Pico chemilumines-
cent substrate and Bio Max light-1 film, Kodak®. Stress protein levels
(arbitrary units) were determined by computer-assisted densitometric analysis
(Photo-Capt software) of immunoreactive bands. Values of controls were
normalized to 100% and that of experimental cultures were expressed as
percent of controls.
2.7. Statistical methods
Data were expressed as mean±standard deviation (SD). Statistical
significance was assessed by Student's t test. P value adjustment for multiple
comparisons was done by the Holm (sequential Bonferroni) correction method.
Pb0.05 was considered statistically significant.
3. Results
3.1. Determination of cytotoxic concentrations of lithium
Fig. 1 shows that Li2CO3 or LiCl, after 3 days of exposure,
induced similar dose-dependant decreases of the cell number
and of the total protein content in cultures. The lowest
concentration that significantly inhibited cell growth (LOEC)
was 2 mM and concentration decreasing cell growth by 50%
(IC50) was about 5 mM. Cell growth was completely inhibited
by 10 mM, the number of cells being similar at the beginning
and at the end of experiment. Sublethal concentration (SL) was
12 mM, 5%±4 dead cells being found by Trypan blue
coloration.Fig. 1. Dose effects of lithium on growth of A549 cells cultured for 3 days in
presence of Li2CO3 or LiCl. Values correspond to the cell number (N) or the total
protein content (P) in Li-treated cultures (percent of controls normalized to
100%). Values are the mean of 3 cultures/concentration±standard deviation.
Student t test: **Pb0.01 compares Li-treated cultures to controls.
metabolism
3.39±1.26 6.36 Cytochrome P450 IIF1 (CYP2F1)
1.69±0.27 2.60 Mitochondrial cytochrome P450
(CYP11A1)
For Li 5 mM, values correspond to the mean of the ratios of two separate
experiments, each including analysis of duplicate spots for each gene±SD For
Li 10 mM, values correspond to the mean of the ratios of two spots from one
experiment.3.2. Differential expression of stress-related genes in 5 or
10 mM Li2CO3-treated cells using cDNA macroarrays
Expression of genes was analysed in cells cultured for 3 days
in presence of lithium concentrations of 5 and 10 mM, that
inhibited cell growth by 50 and 100% respectively (Fig. 1).
Ratio between expression of transcripts from Li treated cells and
controls are reported in Table 1. For Li 5 mM, values
correspond to the mean of ratio of two separate experiments,
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As compared to controls normalized to 100%, it can be seen
that variations between the two experiments were, for the most
part, lower than ±20%. As the procedure was relatively
reproducible, only one experiment was performed to analyse
effects of 10 mM Li. As recommended by the manufacturer,
changes were only considered as significant when the ratios
were b0.70 or N1.5.
According to cell growth arrest induced by 10 mM Li,
transcript level of cyclin-dependant kinase inhibitor p21
(CDKN1A) was found to be increased (ratio: 3.2) and that of
proliferating cell nuclear antigen (PCNA) decreased (ratio: 0.3).
Moreover, gene coding for anti-apoptotic BAG-1 was strikingly
down-regulated by 5 and 10 mM Li (ratio: 0.16).
Concerning enzymes involved in antioxidant defences, a
decrease of the transcription level of genes coding for cytosolic
(SOD1) and mitochondrial (SOD2) superoxide dismutase
(ratio: 0.75, 0.6) and paraoxonase 2 (PON2, ratios 0.39, 0.28)
was observed. No significant change of genes encoding
glutathione peroxidase (GPx) or glutathione-S-transferase 12
(GST12) was observed, whereas glutathione reductase (GRase)
gene expression appeared moderately increased (ratio 1.5) by
10 mM lithium.
About detoxification mechanisms, we found a dose-
dependent up-regulation of genes coding for mitochondrial
cytochrome P450 (CYP11A1, ratios 1.7–2.6) and microsomal
CYP2E1, (ratios: 2.2–2.6) and CYP2F1 (ratios: 3.4–6.3).Fig. 2. Western blotting showing stress protein expression in control A549 cells (C) or
of protein (20 μg) were resolved by SDS-PAGE on 10% polyacrylamide gels.Among genes encoding molecular chaperones, most HSP
genes were down-regulated, except for HSP90 and HSP70
family genes. Indeed, no significant change of the HSP90A, B
and HSP73 genes was noted, while a moderate upregulation of
the gene coding for heat shock-related 70 kDa protein2 was
found (ratio: 1.5). Genes coding for mitochondrial GRP75 and
ER proteins GRP78, GRP94 and calreticulin were found to be
down-regulated in lithium treated cells.
3.3. Changes in the expression level of stress proteins induced
by lithium carbonate
Expression of some stress proteins (HSP and GRP) was
investigated on Western blot in order to confirm the results
obtained with the cDNA-array analysis. Immunoblot in Fig. 2A
shows that the antibody anti-GRP94 immunodetected 2 protein
bands of about 98 and 105–108 kDa. The 98 kDa protein
corresponds certainly to GRP94 (also known as gp96, ERp99)
and the 105–108 kDa protein (named P105) could be an
isoform of GRP94. Indeed, the anti-KDEL antibody immuno-
detected P105, as well as GRP94 and GRP78 (Fig. 2B).
Moreover, a protein band of molecular weight similar to that of
P105 protein was recognized by a monoclonal anti-phospho-
serine antibody (Fig. 2B) suggesting that P105 could be a
phosphorylated isoform of GRP94.
Densitometric analyses of immunoreactive bands (Table 2)
showed that GRP78 and GRP94 expression was moderatelyexposed to Li2CO3 (Li), tunicamycin (Tu) and thapsigargin (Th). Equal amounts
Table 3
Dose effects of tunicamycin and thapsigargin on cell growth and stress protein
expression in A549 cells cultured for 3 days in presence of the chemicals
Tunicamycin
0.5 μg/ml 1 μg/ml 1.5 μg/ml
Growth rate 99±6 70±5 ** 46±6 **
P105 kDa 125±14 149±14** 245±55**
GRP94 145±18** 685±115** 914±116**
GRP78 410±80* 1372±139** 1598±113**
HSP90 89±11 81±13 77±8**
HSP72/73 99±14 53±17** 58±12**
HSP27 110±20 100±26 64±29*
Thapsigargin
4 nM 6 nM 8 nM
Growth rate 90±9 67±8 ** 42±4**
P105 kDa 121±15 181±17** 187±44**
GRP94 530±150** 683±105** 844±99**
GRP78 290±38** 715±65** 1503±120**
HSP90 86±10* 72±10** 78±6**
HSP72/73 93±8 81±13 86±11
HSP27 97±12 101±7 85±12*
Values are expressed as percent of controls and correspond to the mean of 2
separate experiments, each including 3 independent cultures by culture
condition±standard deviation.
Student t test: *Pb0.05, **Pb0.01.
Table 2
Dose-related changes of stress protein expression in A549 cells cultured for
3 days in presence of Li2CO3 or LiCl
Controls 2 mM 4 mM 6 mM 8 mM 10 mM
P 105 kDa
Li2CO3 100±17 115±8 122±16 155±32* 186±14** 208±63**
LiCl 100±7 113±3 121±12 120±11* 138±19* 206±16**
GRP 94
Li2CO3 100±10 102±11 95±7 94±6 85±9 80±15
LiCl 100±9 106±6 102±1 95±3 85±3* 86±4*
GRP78
Li2CO3 100±12 110±15 98±7 108±11 80±5* 75±15**
HSP 90
Li2CO3 100±7 104±3 101±2 106±10 107±16 102±11
LiCl 100±6 108±8 110±11 101±6 103±3 105±4
HSP 72i
Li2CO3 100±5 113±7 110±12 123±15* 125±16* 130±15*
LiCl 100±5 110±6 115±6 127±6* 123±3* 126±5*
HSP 27
Li2CO3 100±7 102±12 89±24 104±23 117±16 125±9*
LiCl 100±16 110±16 108±18 114±18 138±4* 132±8*
Values are expressed as percent of controls and correspond to the mean of 6
immunoblots corresponding to 2 separate experiments, each including 3
independent cultures by Li concentration±standard deviation. Student t test:
*Pb0.05, **Pb0.01.
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whereas a dose-dependant over-expression of P105 occurred
from 6 to 10 mM.
No significant expression changes of HSP90 were detected.
Conversely, HSP27 and inducible HSP72 were found to be
moderately over-expressed for lithium concentrations higher
than 8 and 6 mM respectively.
3.4. HSP and GRP expression changes induced by tunicamycin
and thapsigargin
We hypothesized that over-expression of P105 would be
related to ER stress. To try to identify molecular mechanisms
underlying P105 over-expression, we analysed stress protein
expression changes triggered by tunicamycin and thapsigargin,
two classical inducers of ER stress. A549 cells were cultured for
3 days in presence of each chemical at concentrations inducing
cell growth inhibitions similar to that induced by lithium as
reported in Table 3.
As shown in Fig. 2C and Table 3, tunicamycin and
thapsigargin induced, like lithium, a dose-related over-expres-
sion of P105, but also a very strong over-expression of GRP78
and GRP94, not observed with lithium. Conversely, GRP90,
HSP72/73 and HSP 27 expressions were found to be decreased.
4. Discussion
The aim of this study was to determinate lithium concentra-
tions that inhibited A549 cell growth (without inducinglethality) and to analyse changes of some stress-related genes
or proteins.
After 3 culture days in presence of lithium, a dose-dependant
cell growth inhibition was found for concentrations ranging
from 2 mM (toxicity threshold) to 12 mM (lethality threshold),
IC50 being at 5 mM. Similar results were obtained using lithium
carbonate or lithium chloride.
Using cDNA macroarrays, differential expression of some
stress related genes was analysed in cells cultured for 3 days in
presence of 5 and 10 mM lithium. As expected because of the
cell growth inhibition induced by Li treatment, the expression
level of cyclin-dependant kinase inhibitor p21 (PCNA) was
found to be decreased and that of proliferating cell nuclear
antigen (CDKN1A) increased. CDKN1A, also known as
WAF1, can induce G1 arrest and block entry into S phase
either by inactivating cdks or by inhibiting activity of PCNA
[36].
Moreover, BAG-1 gene was strongly down-regulated, while
chronic treatment at therapeutic relevant lithium concentration
was reported to increase BAG-1 protein expression [37]. BAG1
is known to have anti-apoptotic and neuroprotective effects and
to regulate HS70s activities by controlling their ATP cycles
[38–40].
Concerning genes involved in antioxidant defences, no
significant change of genes encoding glutathione peroxidase
(GPx) or glutathione-S-transferase 12 (GST12, which also has
peroxidase activity), was observed. On the other hand, genes
coding for catalase, cytosolic and mitochondrial superoxydis-
mutase (SOD1, SOD2) and paraoxonase 2 (PON2) were found
to be down-regulated by lithium. PON2 is an aryl-esterase
known to prevent LDL lipid peroxidation and to reverses mildly
oxidized LDL [41].
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mediated by oxidative stress leading to high levels of lipid
peroxidation [15,16,42,43]. We hypothesized that inhibition of
SOD gene transcription results probably in lower SOD activities
leading to high intracellular levels of O2
°− and secondarily the
production of OH° radical through Fenton-type reaction known
to initiate lipid peroxidation. Moreover, through oxidative
modifications, superoxide ions can inhibit GPx activity [44].
Inhibition of GPx activity during lithium treatment was also
reported by Oktem et al. [17] and Erakovic et al. [45]. We have
also observed a decrease of GPx activity in the kidneys and the
liver of rats treated by lithium for 1 month, having serum
lithium concentrations of 1 mM [43]. At the same time, SOD
activities were found to be increased confirming the hypothesis
that lithium induced the production of superoxide ions [43].
Similarly, intraperitoneal administration of lithium (2 mEq/kg/
day) was reported to increase SOD activity in the brain after
24 h [46], but an inhibition was observed with higher doses
(10 mEq). These results show that, the up or down-regulation of
SOD, GPX and catalase activities is closely related to lithium
concentrations and levels of ROS production.
At therapeutic relevant concentrations, lithium was found to
decrease vulnerability of human neural cells to subsequent
cellular injury induced by exogenously added H2O2 [20]
Similarly, Shao et al. [19] showed that lithium pre-treatment
protected cerebral cortical cells in primary culture from H2O2-
induced cell death and glutamate-induced lipid peroxidation,
that was correlated to increased intracellular levels of GSH and
glutamate cysteine ligase expression [47].
Together, these studies show that, at therapeutic concentra-
tions, lithium can cause a moderate oxidative stress leading to
an adaptative response, i.e. resulting in an increase of
antioxidant defences [43,46,47]. At higher concentration, Li-
induced oxidative stress can exceed cellular detoxification
capacities that can result in GSH depletion [48], and/or
inhibition of antioxidant enzyme activities [17,45]. This could
explain that, according to antioxidant and/or adaptative
capacities of cells or organs, similar lithium concentrations
can display neuroprotective or conversely toxic effects.
Among genes involved in cell detoxification, a clear over-
expression of genes coding for cytochrome P450 (CYP2F1,
CYP2E1) was observed. The phase I cytochome P450
isoenzymes generally catalyse the metabolism of endogenous
and foreign compounds to metabolites that can be more easily
eliminated. However, during the cytochrome P450 cycle,
reactive oxygen species (ROS) and bioactivated metabolites
are produced which are highly reactive with endogenous lipid,
protein and/or DNA, causing lipid peroxidation, protein
dysfunctions, cell death and gene mutations [49,50]. It was
particularly shown that intracellular production of ROS and
lipid peroxidation levels were higher in CYP2E1-expressing
HepG2 than in control cells that do not express CYP2E1 [51].
These observations suggest that, in certain conditions, CYP2E1
(and perhaps CYP2F1) over-expression induced by high lithium
concentrations may be detrimental for cells.
As oxidative stress could induce protein conformational
changes and misfolding, more attention was paid to theexpression of molecular chaperones (HSP, GRP) involved in
quality control of cytosolic and ER proteins.
Under our experimental conditions, lithium did not activate
heat shock transcription factor 1 (HSF1) and none of the genes
coding for HSPs or GRPs were found to be significantly up-
regulated. Conversely, some of them were found to be down-
regulated: cytosolic 70.1 (also known as HSP72), HSP27,
HSP32, HSP105, ER resident HSP47, calreticulin, GRP78,
GRP94, and mitochondrial HSP10, HSP60, GRP75.
Surprisingly, some discrepancy appeared when expression of
proteins was analysed. Indeed, a moderate over-expression of
HSP27 and HSP72 was found for lithium concentrations higher
than 8 mM. This can result from a transient up-regulation of
genes at the beginning of lithium exposure, and a life duration
of the proteins longer than 3 days. This combination of
phenomena could explain the lack of under-expression of
HSP27 and HSP72 in spite of gene down-regulation found at
the 3rd day of exposure. Moreover it is possible that our anti-
HSP72 antibody also react with the heat shock-related 70-kDa
protein 2, which gene was found to be up-regulated by Li 5 mM.
Lithium-induced oxidative stress could account for the over-
expression of HSP72 and HSP27. HSP72 has been proposed as a
general response to oxidative stress [23,24,27,52] and HSP27
was reported to have protective activity against oxidative stress
by inducing increased levels of GSH [24,53,54].
According to the gene down-regulation, GRP78 and GRP94
expression was moderately inhibited by the highest lithium
concentrations. Dey et al. [55] found a decreased protein and
mRNA expression of GRP78 and GRP94 in CYP2E1-over
expressing HepG2 cells, suggesting that lithium-mediated
oxidative stress in the RE can account for the down-regulation
of GRPs in lithium-treated A549 cells. The fact that
peroxidative stress was found to be associated with a down-
regulation of GRP78 and GRP94 mRNA levels in neuronal cell
cultures is interesting in this respect [56].
Conversely, Shao et al. [55] reported that lithium chronic
treatment for 1 week at therapeutic relevant concentrations
modestly increased both mRNA and protein levels of GRP78
and GRP94 in primary culture of rat cerebral cortical cells. We
failed to observe similar change of GRP78 and GRP94 protein
expression in SH-SY5Y cells after chronic exposure to low Li
concentrations (not shown). Cerebral cortical cells were
cultured in culture medium supplemented with B27 containing
a cocktail of antioxidants (catalase, SOD, GSH…), that limit
harmful effects of oxidative stress induced by Li.
Together, these results suggest that, depending of the
level of oxidative stress, GRP78 and GRP94 can be up or
down-regulated.
In addition, a possible isoforme of GRP94, namely P105
was found to be overexpressed. Indeed, P105, like GRP94 and
GRP78, both containing ER retention signal, were recognized
by the anti-KDEL antibody. Moreover, this protein seems to be
phosphorylated on serine residues. Post-translational modifica-
tions of phosphorylation [58,59] and/or glycosylation levels
[60,61] can result in GRP94 apparent mass changes. Phos-
phorylation probably regulate GRP94 activity, since phos-
phorylated GRP94 does not associate with it preferred
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GRP94 is a glycoprotein with six potential Asn glycosylation
sites but only Asn 196 is used in physiological conditions.
However, in cells overexpressing GRP94, a small fraction of
this protein was found to be hyperglycosylated on Asn 424,
460, and 481 [63].
The role of GRP94 is not yet well known. A fundamental
difference between GRP94 and other ER chaperones likes
GRP78 or calnexin is that GRP94 interacts with a restricted set
of protein substrates. In addition, GRP94 associates with
advanced folding intermediates of its substrate proteins, or with
incompletely assembled oligomers, but not with early folding
intermediates [62,64].
It is well known that over-expression of GRP94 and
GRP78 occurs under stressing conditions such as ER Ca++
depletion, glucose starvation, low extracellular pH or oxidative
stress, leading to accumulation of misfolded proteins in the ER
[30–32,65]. To try to identify molecular mechanisms under-
lying P105 (probable GRP94 isoform) over-expression, we
analysed stress protein expression changes triggered by tunica-
mycin that inhibits N-linked glycosylation and by thapsigargin,
that inhibits ER Ca2+ ATPases. Both tunicamycin and
thapsigargin induced significant over-expressions of P105
and above all of GRP78 and GRP94, whereas HSP 90, 72/73
and 27 expression was decreased. This is in agreement with
previous works showing that the synthesis of many proteins
was inhibited when the cells undergo ER stress [66–68].
Under lithium treatment, P105 and also HSP72 and 27 were
moderately over-expressed, whereas GRP94 and 78 were
under-expressed, suggesting that lithium effects are not related
to defect in N-linked glycosylation and/or to changes in calcium
homeostasis. In agreement with our results, Shao et al. [57] did
not find significant changes of basal intracellular calcium
concentration in rats cerebral cortical cells cultured for 1 week
in presence of 0.5, 1 and 2 mM of Li.
In conclusion, our work suggests that lithium toxicity is
partly related to oxidative stress resulting from up-regulation of
at least two cytochrome P450 genes able to generate ROS and
down-regulation of various genes coding for antioxidant
enzymes and/or involved in the prevention of lipid peroxida-
tion. Moreover the ability of lithium to down-regulate genes
coding for anti-apoptotic gene BAG-1 and most of the
molecular chaperones might account for its toxicity since
these proteins are critical for the survival of cells exposed to a
variety of physiological stresses.
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